152 related articles for article (PubMed ID: 28692818)
1. Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies.
Chaudhri NA; Aljurf M; Almohareb FI; Alzahrani HA; Bashir Q; Savani B; Gupta V; Hashmi SK
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):173-177. PubMed ID: 28692818
[TBL] [Abstract][Full Text] [Related]
2. The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
Thakar MS; Broglie L; Logan B; Artz A; Bunin N; Burroughs LM; Fretham C; Jacobsohn DA; Loren AW; Kurtzberg J; Martinez CA; Mineishi S; Nelson AS; Woolfrey A; Pasquini MC; Sorror ML
Blood; 2019 Feb; 133(7):754-762. PubMed ID: 30545834
[TBL] [Abstract][Full Text] [Related]
3. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2008-2009: report on behalf of the Eastern Mediterranean Bone Marrow Transplantation (EMBMT) Group.
Mohamed SY; Fadhil I; Hamladji RM; Hamidieh AA; Fahmy O; Ladeb S; Alimoghaddam K; Elhaddad A; Nacer RA; Alsharif F; Rasheed W; Jahani M; Mousavi SA; Alseraihy A; Abdel-Rahman F; Al Jefri A; Hussein AA; Alabdulaaly A; Ibrahim A; Bekadja MA; Abboud M; Ahmed P; Dennison D; Bakr M; Benchekroun S; Hussain F; Othman TB; Aljurf M; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2011; 4(2):81-93. PubMed ID: 21727769
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic cell transplantation for nonmalignant disorders.
Tolar J; Mehta PA; Walters MC
Biol Blood Marrow Transplant; 2012 Jan; 18(1 Suppl):S166-71. PubMed ID: 22226101
[TBL] [Abstract][Full Text] [Related]
5. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation.
Dietz AC; Mehta PA; Vlachos A; Savage SA; Bresters D; Tolar J; Boulad F; Dalle JH; Bonfim C; de la Fuente J; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 May; 23(5):726-735. PubMed ID: 28115275
[TBL] [Abstract][Full Text] [Related]
6. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.
Dietz AC; Savage SA; Vlachos A; Mehta PA; Bresters D; Tolar J; Bonfim C; Dalle JH; de la Fuente J; Skinner R; Boulad F; Duncan CN; Baker KS; Pulsipher MA; Lipton JM; Wagner JE; Alter BP
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1422-1428. PubMed ID: 28533057
[TBL] [Abstract][Full Text] [Related]
7. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up.
Alter BP; Giri N; Savage SA; Rosenberg PS
Haematologica; 2018 Jan; 103(1):30-39. PubMed ID: 29051281
[TBL] [Abstract][Full Text] [Related]
8. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.
Srinivasan R; Takahashi Y; McCoy JP; Espinoza-Delgado I; Dorrance C; Igarashi T; Lundqvist A; Barrett AJ; Young NS; Geller N; Childs RW
Br J Haematol; 2006 May; 133(3):305-14. PubMed ID: 16643433
[TBL] [Abstract][Full Text] [Related]
9. Disease-specific hematopoietic stem cell transplantation in children with inherited bone marrow failure syndromes.
Li Q; Luo C; Luo C; Wang J; Li B; Ding L; Chen J
Ann Hematol; 2017 Aug; 96(8):1389-1397. PubMed ID: 28623394
[TBL] [Abstract][Full Text] [Related]
10. Inherited bone marrow failure syndromes: considerations pre- and posttransplant.
Alter BP
Blood; 2017 Nov; 130(21):2257-2264. PubMed ID: 29167174
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes.
Sakaguchi H; Yoshida N
Int J Hematol; 2022 Jul; 116(1):16-27. PubMed ID: 35633493
[TBL] [Abstract][Full Text] [Related]
12. Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival.
Htut M; D'Souza A; Krishnan A; Bruno B; Zhang MJ; Fei M; Diaz MA; Copelan E; Ganguly S; Hamadani M; Kharfan-Dabaja M; Lazarus H; Lee C; Meehan K; Nishihori T; Saad A; Seo S; Ramanathan M; Usmani SZ; Gasparetto C; Mark TM; Nieto Y; Hari P
Biol Blood Marrow Transplant; 2018 Mar; 24(3):478-485. PubMed ID: 29079457
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic stem cell transplantation in Europe 1998.
Gratwohl A; Passweg J; Baldomero H; Hermans J; Urbano-Ispizua A;
Hematol J; 2000; 1(5):333-50. PubMed ID: 11920211
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic Stem Cell Transplantation for Patients with Paroxysmal Nocturnal Hemoglobinuria with or without Aplastic Anemia: A Multicenter Turkish Experience.
Yılmaz F; Soyer N; Cengiz Seval G; Civriz Bozdağ S; Topcuoğlu P; Ünal A; Kaynar L; Özgür G; Sucak G; Göker H; Velet M; Özdoğu H; Yılmaz M; Kaya E; Salim O; Deveci B; Karadoğan İ; Saydam G; Şahin F; Vural F
Turk J Haematol; 2021 Aug; 38(3):195-203. PubMed ID: 34057336
[TBL] [Abstract][Full Text] [Related]
15. [111th Scientific Meeting of the Japanese Society of Internal Medicine: Invited Lecture; 3. Pathophysiology and treatment of bone marrow failure syndromes].
Ozawa K
Nihon Naika Gakkai Zasshi; 2014 Sep; 103(9):2062-73. PubMed ID: 27522754
[No Abstract] [Full Text] [Related]
16. Guest Editorial: Inherited bone marrow failure and myelodysplasia in children: how much do we know about pediatric diseases?
Manabe A
Int J Hematol; 2016 Apr; 103(4):359. PubMed ID: 26899856
[No Abstract] [Full Text] [Related]
17. Hematopoietic stem cell transplantation in the Eastern Mediterranean Region (EMRO) 2011-2012: A comprehensive report on behalf of the Eastern Mediterranean Blood and Marrow Transplantation group (EMBMT).
Aljurf M; Nassar A; Hamidieh AA; Elhaddad A; Hamladji RM; Bazarbachi A; Ibrahim A; Ben Othman T; Abdel-Rahman F; Alseraihy A; Fahmy O; Hussein AA; Alabdulaaly A; Adil S; Alkindi SS; Bayoumy M; Dennison D; Bekadja MA; Redhouane AN; Rasheed W; AlSagheir A; Alsudairy R; Ladeb S; Benchekroun S; Ramzi M; Ahmed P; ElSolh H; Ahmed SO; Hussain F; Ghavamzadeh A
Hematol Oncol Stem Cell Ther; 2015 Dec; 8(4):167-75. PubMed ID: 26452331
[TBL] [Abstract][Full Text] [Related]
18. [Change in paradigm in the treatment of pediatric acquired bone marrow failure syndromes in Hungary].
Kállay K; Csomor J; Ádám E; Bödör C; Kassa C; Simon R; Kovács G; Péter G; Ottóffy G; Bartyik K; Kiss C; Masát P; Réti M; Tóth B; Kriván G
Orv Hetil; 2018 Oct; 159(42):1710-1719. PubMed ID: 30334483
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.
Dalle JH; Peffault de Latour R
Int J Hematol; 2016 Apr; 103(4):373-9. PubMed ID: 26872907
[TBL] [Abstract][Full Text] [Related]
20. The Second Pediatric Blood and Marrow Transplant Consortium International Consensus Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Defining the Unique Late Effects of Children Undergoing Hematopoietic Cell Transplantation for Immune Deficiencies, Inherited Marrow Failure Disorders, and Hemoglobinopathies.
Dietz AC; Duncan CN; Alter BP; Bresters D; Cowan MJ; Notarangelo L; Rosenberg PS; Shenoy S; Skinner R; Walters MC; Wagner J; Baker KS; Pulsipher MA
Biol Blood Marrow Transplant; 2017 Jan; 23(1):24-29. PubMed ID: 27737772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
